The present invention relates to a compound of the general formula (1).
The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
本发明涉及通式(1)的化合物。
式(1)化合物适用于治疗哺乳动物(如人类)中与半凝集素(如半凝集素-3)与
配体结合有关的紊乱的方法。此外,本发明还涉及一种治疗哺乳动物(如人类)中与半凝集素(如半凝集素-3)与
配体结合有关的紊乱的方法。